Literature DB >> 29859289

The pathogenesis of steroid-induced osteonecrosis of the femoral head: A systematic review of the literature.

Ao Wang1, Ming Ren1, Jincheng Wang2.   

Abstract

Steroid (glucocorticoid)-induced osteonecrosis of the femoral head (SONFH) is a metabolic disease that occurs due to the use of glucocorticoid drugs, leading to impaired blood supply to the femoral head and death of bone cells and bone marrow composition, which in turn lead to structural change, collapse of the femoral head, and articular dysfunction. SONFH is a challenging disorder to treat in adults due to frequent collapse of the femoral head and dysfunction of the hip joint. Eventually, patients require joint arthroplasty surgery, which severely impairs the patients' quality of life. However, the exactly pathogenesis of SONFH is still not clear. Recently, as the development of precision medicine and lucubrating on stem cell and molecular biology, the exact pathogenesis of SONFH is being investigated and more new treatments are being explored. This review article discusses five major theories about the pathogenesis of SONFH.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Avascular necrosis; Femoral head; Osteonecrosis; Pathogenesis; Treatment

Mesh:

Substances:

Year:  2018        PMID: 29859289     DOI: 10.1016/j.gene.2018.05.091

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  39 in total

1.  Cell therapy for osteonecrosis of femoral head and joint preservation.

Authors:  You Seung Chun; Dong Hwan Lee; Tae Gu Won; Chan Sik Kim; Asode Ananthram Shetty; Seok Jung Kim
Journal:  J Clin Orthop Trauma       Date:  2021-11-27

2.  Neohesperidin promotes the proliferation and osteogenic differentiation of BMSCs via BMP2-Wnt/β-catenin pathway.

Authors:  Shuai Yuan; Chuanxin Zhang; Bo Wang
Journal:  Cell Cycle       Date:  2021-12-17       Impact factor: 4.534

3.  Osteonecrosis of Bilateral Distal Femurs in a Pregnant Patient Following Antenatal Betamethasone.

Authors:  Rafal S Ali; Hussein Al-Sudani; Irene J Tan
Journal:  Cureus       Date:  2022-03-01

4.  IL-34 Aggravates Steroid-Induced Osteonecrosis of the Femoral Head via Promoting Osteoclast Differentiation.

Authors:  Feng Wang; Hong Sung Min; Haojie Shan; Fuli Yin; Chaolai Jiang; Yang Zong; Xin Ma; Yiwei Lin; Zubin Zhou; Xiaowei Yu
Journal:  Immune Netw       Date:  2022-03-31       Impact factor: 5.851

5.  [Treatment of osteonecrosis of the femoral head with vascularized bone grafting].

Authors:  Haibo Ding; Yang Wang; Yun Lu
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-03-15

6.  [Experimental study on improvement of osteonecrosis of femoral head with exosomes derived from miR-27a-overexpressing vascular endothelial cells].

Authors:  Gensheng Zhang; Ruiyu Liu; Xiaoqian Dang; Jichao Liu; Haibin Jiao
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-03-15

7.  CircPVT1 up-regulation attenuates steroid-induced osteonecrosis of the femoral head through regulating miR-21-5p-mediated Smad7/TGFβ signalling pathway.

Authors:  Yangquan Hao; Chao Lu; Baogang Zhang; Zhaochen Xu; Hao Guo; Gaokui Zhang
Journal:  J Cell Mol Med       Date:  2021-03-18       Impact factor: 5.310

8.  Total flavonoids of Rhizoma drynariae ameliorate steroid‑induced avascular necrosis of the femoral head via the PI3K/AKT pathway.

Authors:  Wenxue Lv; Mingxiu Yu; Qingyi Yang; Peng Kong; Bing Yan
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

9.  Hyperoside exerts osteoprotective effect on dexamethasone-induced osteoblasts by targeting NADPH Oxidase 4 (NOX4) to inhibit the reactive oxygen species (ROS) accumulation and activate c-Jun N-terminal kinase (JNK) pathway.

Authors:  Siqi Fan; Haida Pan; Jiaxing Huang; Zhiqiang Lei; Jinfu Liu
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

10.  Prevalence of avascular necrosis in idiopathic inflammatory myopathies: a single-centre experience.

Authors:  Khalil I Bourji; Christopher A Mecoli; Julie J Paik; Jemima Albayda; Eleni Tiniakou; William Kelly; Thomas E Lloyd; Andrew Mammen; Shivani Ahlawat; Lisa Christopher-Stine
Journal:  Rheumatology (Oxford)       Date:  2022-03-02       Impact factor: 7.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.